Qsymia (Phentermine/Topiramate) for Obesity

Overview
Qsymia is a prescription drug approved by the Food and Drug Administration (FDA) for chronic weight management in conjunction with a reduced-calorie diet and exercise. Qsymia may be prescribed for adults with a body mass index (BMI) of 30 or greater. Adults with a BMI of 27 or greater may be considered candidates for Qsymia if they have at least one weight-related medical condition. Qsymia is a combination of two drugs, Phentermine and Topiramate.

Phentermine is a stimulant related to amphetamines. It is believed that Phentermine works by suppressing the appetite. Topiramate is an anticonvulsant, or anti-seizure drug, that causes weight loss as a side effect. It is not known how Topiramate works.

How do I take it?
Prescribing information states that Qsymia should be taken once daily.

Qsymia comes in capsule form.

Side effects
The FDA-approved label for Qsymia lists common side effects including dizziness, foul taste in the mouth, “pins and needles” sensation, insomnia, dry mouth, and constipation.

Rare but serious side effects listed for Qsymia include increased heart rate, suicidal thoughts or behavior, mood and sleep disorders, vision problems, hypoglycemia, and metabolic acidosis.

For answers to frequently asked questions about exposure to Phentermine and Topiramate during pregnancy and breastfeeding, visit the experts at MothertoBaby.org.

For more details about this treatment, visit:
Qsymia – Vivus
https://qsymia.com/